Wnt signaling plays important roles during vertebrate development, including left-right axis specification as well as heart and kidney organogenesis. We identified a homozygous human WNT11 variant in an infant with Situs inversus totalis, complex heart defects and renal hypodysplasia, and we used Xenopus embryos to functionally characterize this variant. WNT11c.814delG encodes a protein with reduced stability that lost signaling activity in vivo. This is remarkable, because the variant encodes a truncated ligand with nearly identical length and predicted structure to dominant-negative Wnts. Furthermore, we demonstrate that alteration of the truncated C-terminal end can restore stability and signaling activity similar to Xenopus dominant-negative Wnt11b. Our study also suggests similar functions for WNT11 in human development as described in model organisms. Therefore, biallelic WNT11 dysfunction should be considered as novel genetic cause in syndromal human phenotypes presenting with congenital heart defects and renal hypoplasia, with or without laterality defects. The work presented here enhances our understanding of human development and structure-function relationships in Wnt ligands.
A homozygous human WNT11 variant is associated with laterality, heart and renal defects
- Award Group:
- Funder(s): Deutsche Forschungsgemeinschaft
- Award Id(s): WA3365/2-1,WA3365/5-1,WA3365/6-1,431984000,390939984,503306912
- Funder(s):
- Award Group:
- Funder(s): HORIZON EUROPE European Research Council
- Award Id(s): 716344
- Funder(s):
- Award Group:
- Funder(s): Medizinische Fakultat der Albert-Ludwigs-Universitat Freiburg
- Award Id(s): MOTI-VATE
- Funder(s):
Henrike Berns, Damian Weber, Maximilian Haas, Zeineb Bakey, Magdalena Maria Brislinger-Engelhardt, Miriam Schmidts, Peter Walentek; A homozygous human WNT11 variant is associated with laterality, heart and renal defects. Dis Model Mech 2025; dmm.052211. doi: https://doi.org/10.1242/dmm.052211
Download citation file:
Advertisement
Cited by
Interviews with Biologists @ 100 conference speakers

Explore our interviews with keynote speakers from the Biologists @ 100 conference, hosted to celebrate our publisher’s 100th anniversary, where we discuss climate change and biodiversity with Hans-Otto Pörtner and Jane Francis, health and disease with Charles Swanton and Sadaf Farooqi, and emerging technologies with Manu Prakash and Jennifer Lippincott-Schwartz.
A new perspective on disease research
DMM publishes perspectives – peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
History of our journals

As our publisher, The Company of Biologists, turns 100 years old, read about DMM’s history and explore the journey of each of our sister journals: Development, Journal of Cell Science, Journal of Experimental Biology and Biology Open.
Other journals from
The Company of Biologists